The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

5 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties.EBI
Alma Mater Studiorum - University of Bologna
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.EBI
Alma Mater Studiorum - University of Bologna
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic Warheads.EBI
Alma Mater Studiorum - University of Bologna
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.EBI
Alma Mater Studiorum - University of Bologna
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.EBI
Alma Mater Studiorum - University of Bologna